Avior Wealth Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 246 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avior Wealth Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$526
-12.9%
450.0%0.00%
Q2 2023$604
-19.0%
450.0%0.00%
Q1 2023$746
-10.9%
450.0%0.00%
Q4 2022$837450.0%0.00%
Q3 2022$0450.0%0.00%
Q2 2022$0450.0%0.00%
Q1 2022$0450.0%0.00%
Q4 2021$0450.0%0.00%
Q3 2021$0450.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders